Best Regulatory Intelligence Software for Medical Devices 2026: Unbiased Comparison of 8 Platforms

Why Medical Device Companies Need Regulatory Intelligence Software

The regulatory landscape for medical devices has never been more complex, and it is accelerating. In 2026 alone, manufacturers face the FDA's Quality Management System Regulation (QMSR) transition, the EU's EUDAMED database becoming functionally mandatory, Health Canada's regulatory modernization efforts, and a patchwork of over 150 distinct national regulatory frameworks that change constantly. A single Class II device targeting 15 markets can be subject to hundreds of regulatory updates per year.

Manual tracking — spreadsheets, bookmarked agency websites, email alerts from trade associations — cannot keep pace. The consequences of missing a critical change are tangible: delayed market entry, rejected submissions, surprise audit findings, and in the worst cases, product recalls. Regulatory intelligence software exists to solve this problem by continuously monitoring, filtering, and delivering the regulatory changes that matter to your specific products and markets.

Important disclosure: This guide is not sponsored by any vendor. We have no financial relationship with any platform reviewed here. Many regulatory intelligence comparisons online are published by the vendors themselves or their paid partners. This is an independent assessment.

What Makes Medical Device Regulatory Intelligence Unique

Regulatory intelligence for medical devices is fundamentally different from pharmaceutical regulatory intelligence, and many platforms on the market were built for pharma first. Understanding these differences is critical when evaluating software.

Device classification varies by jurisdiction. A product classified as Class II in the United States might be Class IIa in the EU, Class III in China, and Class IV in Brazil. Each classification triggers different submission requirements, clinical evidence expectations, and post-market obligations. Regulatory intelligence software must track not just the rules but how classification rules apply across markets.

UDI database management. The Unique Device Identification system requires coordination across FDA's GUDID, EUDAMED, and national UDI databases in Japan, South Korea, Australia, and elsewhere. Tracking UDI submission deadlines, database downtime, and format changes is a device-specific need that pharma-oriented platforms typically do not address.

Post-market surveillance across countries. Medical device post-market requirements differ dramatically: Periodic Safety Update Reports (PSUR) under EU MDR, Medical Device Reports (MDR) to the FDA, PMCF studies, vigilance reporting timelines that range from 2 days to 30 days depending on jurisdiction. Tracking these obligations across a global portfolio requires purpose-built capabilities.

Standard updates. Devices must comply with a web of harmonized and de facto standards — ISO 13485, ISO 14971, IEC 62304, IEC 62366, ISO 10993 series, and dozens more. When these standards are revised, the impact on design controls, risk management files, and technical documentation can be extensive. Software that monitors standards changes alongside regulatory changes is essential.

Design control documentation. Unlike pharmaceutical products defined by their active ingredient, medical devices are defined by their design. Changes to design controls, risk analysis, and verification/validation documentation triggered by regulatory changes must be tracked through the design history file (DHF). Integration between regulatory intelligence and design control systems is a uniquely device-centric need.

Country-specific registration pathways. The 510(k), De Novo, and PMA pathways in the US are just the beginning. Every market has its own registration or listing requirements — from CE marking under EU MDR with Notified Body involvement to ANVISA registration in Brazil to NMPA approval in China to the ASEAN CSDT process. Software must map these pathways and track changes to each.

Quick Comparison: 8 Regulatory Intelligence Platforms at a Glance

Platform	Primary Focus	Medical Device Depth	AI Capabilities	Real-Time Updates	Coverage	Pricing Model	Best For
RegDesk	Multi-market pharma/medtech	Good	AI Application Builder, change assessment	Yes	120+ markets	Custom	Mid-size teams with global ambitions
IQVIA Regulatory Intelligence	Large pharma ecosystem	Moderate	NLP-powered RIA assistant	Yes	110+ countries	Enterprise custom	Large pharma already using IQVIA
Cortellis Regulatory Intelligence (Clarivate)	Comprehensive pharma regulatory	Limited	AI Regulatory Assistant, Enhanced Search	Daily updates	80+ markets	Custom enterprise	Pharma-centric teams needing competitive intel
Obsidian Regulatory Intelligence	Official-source monitoring	Good (MedTech filter)	Limited	Real-time	Framework-based	Per-user, published	Teams needing audit-traceable intelligence
Basil Systems (Basil Intel)	Device intelligence (FDA data)	Very strong	AI-powered indexing	Multiple daily updates	Primarily FDA	Contact vendor	US-market device companies, 510(k)/PMA strategy
ArisGlobal LifeSphere	Integrated RIM ecosystem	Moderate	NavaX GenAI, Agentic AI	Yes	Global (ecosystem)	Contact vendor	Enterprise pharma with integrated RIM needs
Freyr RegIntel	Multi-vertical regulatory tracking	Good	Ask freya chatbot, DocChat, KnowledgeGraphs	Yes	200+ markets	Contact vendor	Companies needing multi-product-category coverage
Veeva Vault Regulatory	End-to-end RIM	Moderate	Built-in AI features	Yes	Global	Enterprise custom	Large organizations already using Veeva

Recommended Reading

CMS-FDA RAPID Coverage Pathway: Fast-Track Medicare Coverage for Breakthrough Devices

Reimbursement & Market Access Regulatory2026-04-28 · 11 min read

Detailed Platform Reviews

1. RegDesk — Best for Multi-Market MedTech Teams

RegDesk is an AI-powered Regulatory Information Management (RIM) platform with a strong emphasis on medical device and IVD regulatory intelligence. It provides real-time regulatory monitoring across 120+ markets, country-specific submission templates, and structured impact assessment tools. RegDesk positions itself as a unified platform where regulatory intelligence feeds directly into submission planning and lifecycle management.

Key strengths for medical devices:

• AI Application Builder that automatically generates country-specific submission forms and compliance checklists for medical device registrations
• Structured change assessment features that evaluate the impact of regulatory updates on your specific device registrations
• Country-specific templates aligned to device classification requirements across major and emerging markets
• Integration between regulatory intelligence monitoring and the broader RIM workflow, so changes trigger actionable next steps rather than just alerts
• Coverage of 120+ markets including emerging economies in the Middle East, Africa, Latin America, and Southeast Asia

Limitations:

• Pricing is entirely opaque — "contact sales" model with no published rates, making budget planning difficult
• Relatively newer platform compared to established competitors like IQVIA or Clarivate, which means a shorter track record for long-term customers
• AI-generated submission documents still require thorough expert review; the tool assists but does not replace regulatory expertise
• Competitive intelligence features (tracking competitor approvals, clinical trials) are less developed than platforms like Cortellis or Basil Systems

Pricing: Custom pricing. No published rates or free trial available.

Best for: Mid-size medical device companies (50–500 employees) with global market ambitions that need regulatory intelligence tightly integrated with submission management and RIM processes.

---

2. IQVIA Regulatory Intelligence — Best for Organizations Already in the IQVIA Ecosystem

IQVIA is one of the largest healthcare data and analytics companies globally, and its Regulatory Intelligence offering is part of a vast ecosystem spanning clinical trials, real-world evidence, commercial analytics, and regulatory compliance. The platform provides broad coverage of 110+ countries with NLP-powered tools for regulatory monitoring and analysis.

Key strengths for medical devices:

• NLP-powered Regulatory Intelligence Assistant (RIA) that can parse and summarize regulatory documents, extract key data attributes, and support comparative analysis across markets
• Extremely broad country and regional coverage backed by IQVIA's global data infrastructure
• Integration with IQVIA's broader platform — if your organization already uses IQVIA for clinical development, safety, or commercial analytics, the regulatory intelligence module connects to that data
• Extensive historical regulatory data, useful for trend analysis and strategic planning

Limitations:

• Medical device coverage is less deep than pharmaceutical coverage — the platform was built pharma-first and device features feel secondary
• Best value is realized when you are already invested in the IQVIA ecosystem; standalone regulatory intelligence is expensive relative to alternatives
• Enterprise pricing and complex contracting processes make this inaccessible for startups and small companies
• The sheer breadth of the platform means it can feel overwhelming for teams that only need regulatory intelligence without the broader IQVIA suite

Pricing: Enterprise custom pricing. Significant annual commitments typically required.

Best for: Large pharmaceutical or diversified life sciences companies already using IQVIA's clinical, safety, or commercial platforms that want regulatory intelligence within the same ecosystem.

---

3. Cortellis Regulatory Intelligence (Clarivate) — Best for Pharma-Centric Competitive Intelligence

Cortellis Regulatory Intelligence, part of Clarivate's Cortellis suite, is one of the most established regulatory intelligence platforms in the industry. With over 30 years of curated regulatory data, 300,000+ regulatory reports, and daily updates across 80+ markets, it provides comprehensive coverage primarily oriented toward pharmaceutical and biotech companies. In August 2025, Clarivate launched an AI-powered Regulatory Assistant (fully released in December 2025) and in March 2026 integrated with Anthropic's Claude AI via the Model Context Protocol.

Key strengths for medical devices:

• AI-powered Regulatory Assistant with conversational search, document summarization, version comparison, and multilingual support
• Massive curated regulatory database with expert-analyzed reports rather than raw data dumps
• Integration with the broader Cortellis suite — Competitive Intelligence, Clinical Trials Intelligence, Drug Discovery Intelligence — providing context beyond pure regulatory compliance
• Continuous AI investment, including the 2026 MCP integration that embeds regulatory content into AI workflows
• Strong track record with major pharmaceutical and biotech organizations

Limitations:

• Medical device depth is limited compared to pharma coverage — this is primarily a pharmaceutical regulatory intelligence platform that includes device content, not a device-first platform
• No dedicated device-specific features like UDI tracking, design control integration, or 510(k)/PMA workflow support
• Custom enterprise pricing with no published rates or self-service options
• Best suited for organizations that also need the broader Cortellis competitive and clinical intelligence modules; pure device companies may pay for capabilities they don't use

Pricing: Custom enterprise pricing. No published rates.

Best for: Pharmaceutical companies with medical device divisions, drug-device combination product manufacturers, and organizations that need regulatory intelligence alongside competitive and clinical trial intelligence within a single platform.

---

4. Obsidian Regulatory Intelligence — Best for Audit-Traceable Official-Source Monitoring

Obsidian takes a fundamentally different approach from most competitors: it monitors official government sources directly in real-time, rather than relying on curated analyst summaries. This means every alert can be traced back to the exact source document from the relevant health authority. Obsidian offers dedicated industry verticals, including one for Life Sciences and MedTech that filters regulatory changes relevant to pharmaceutical and medical device companies.

Key strengths for medical devices:

• Direct monitoring of official government sources (FDA, EMA, national competent authorities) with full source traceability — critical for audit readiness and demonstrating due diligence during inspections
• Published per-user pricing with degressive volume discounts, which is unusual transparency in this market
• Real-time detection of regulatory changes rather than batch daily updates
• Dedicated MedTech industry filter that surfaces device-relevant changes from the broader regulatory feed
• REST API and MCP integration for AI agents, enabling automation of intelligence workflows
• Framework-based subscriptions allow teams to monitor specific regulatory frameworks (FDA 21 CFR, EU MDR, ICH Guidelines, AI Act) alongside industry feeds

Limitations:

• No competitive intelligence — Obsidian focuses purely on regulatory monitoring, not competitor tracking, approval analysis, or market intelligence
• Limited analytical depth; the platform tells you what changed but does not provide expert interpretation or impact assessment on your specific products
• Newer platform with a smaller customer base compared to IQVIA, Clarivate, or Veeva
• Device-specific features like classification tools, submission templates, or RIM integration are not part of the core offering

Pricing: Published per-user pricing. Frameworks (up to 4 per subscription) and industry feeds available. Volume discounts from 1 to 50+ seats. 70% discount when combining framework and industry subscriptions.

Best for: Regulatory affairs teams that need reliable, audit-traceable monitoring of regulatory changes from official sources and value transparent, predictable pricing. Particularly well-suited for quality and compliance teams that need to demonstrate they are monitoring regulatory changes proactively.

---

5. Basil Systems (Basil Intel) — Best for US-Market Device Intelligence and 510(k) Strategy

Basil Systems is purpose-built for medical device and diagnostics companies, with deep intelligence on FDA regulatory data including 510(k) submissions, PMA applications, product codes, classification decisions, guidance documents, and clinical trials. The platform uses AI-powered indexing to make all FDA device data searchable and interconnected, providing insights that are difficult or impossible to obtain from the FDA's own databases.

Key strengths for medical devices:

• The most comprehensive FDA device intelligence available commercially — all 510(k), PMA, De Novo, and classification data searchable and linked
• Unique "Ecosystem" feature that visualizes predicate device relationships, allowing teams to identify optimal predicate devices for 510(k) submissions and understand the competitive predicate landscape
• AI-powered indexing of FDA data that connects related submissions, regulations, guidance documents, and product codes
• Multiple daily updates ensuring access to the latest FDA actions, clearances, and guidance changes
• Strong analytics for regulatory strategy — identifying trends in FDA review times, common deficiencies, and clearance rates by product code

Limitations:

• Coverage is primarily US FDA-centric; international regulatory intelligence is limited compared to RegDesk, Freyr, or IQVIA
• Not a full regulatory intelligence monitoring platform — it excels at device-specific data analysis but does not provide broad regulatory change tracking across 100+ markets
• Limited pharmaceutical coverage; not suitable for organizations that need combined drug and device intelligence
• Pricing is not published; contact vendor required

Pricing: Contact vendor for pricing. No published rates.

Best for: US-focused medical device companies that need deep intelligence on FDA 510(k) and PMA data for regulatory strategy, predicate selection, and competitive analysis. Also valuable for consulting firms supporting device clients with US market entry.

---

6. ArisGlobal LifeSphere — Best for Integrated Regulatory Intelligence with RIM

ArisGlobal's LifeSphere platform is a comprehensive regulatory information management suite that includes regulatory intelligence as a module within a broader ecosystem covering regulatory submissions, safety/pharmacovigilance, and quality management. The intelligence module is powered by NavaX, ArisGlobal's cognitive computing engine that has evolved from RPA and machine learning to incorporate Generative AI and Agentic AI capabilities.

Key strengths for medical devices:

• NavaX GenAI chatbot for querying regulatory intelligence using natural language, building a centralized knowledgebase accessible to the entire regulatory team
• Automated impact assessment of regulatory changes on your existing registration records — connects intelligence directly to your product portfolio
• Integrated with the broader LifeSphere RIM suite, so regulatory intelligence feeds into submission planning, registration management, and health authority interactions
• Automated regulatory classification tools that help determine device classification across markets
• 35+ years of life sciences technology experience with a global customer base

Limitations:

• Best value is realized when deployed as part of the full LifeSphere RIM ecosystem; standalone regulatory intelligence is less compelling
• Medical device-specific features are present but the platform's heritage is pharmaceutical
• Enterprise pricing and implementation model means long sales cycles and significant commitments
• The NavaX AI capabilities are impressive but relatively new; organizations should validate AI-generated assessments against expert judgment

Pricing: Contact vendor for pricing. Enterprise model.

Best for: Mid-size to large pharmaceutical or diversified life sciences companies that want regulatory intelligence as part of an integrated RIM platform, particularly organizations that also need safety and pharmacovigilance capabilities from the same vendor.

---

7. Freyr RegIntel (Freya.Intelligence) — Best for Broad Multi-Vertical Coverage

Freyr's regulatory intelligence platform, branded Freya.Intelligence, stands out for its breadth: it covers 200+ markets and extends beyond medical devices to include pharmaceuticals, cosmetics, food supplements, biocides, and other regulated product categories. The platform is AI-driven with a suite of tools including an AI chatbot (Ask freya), document analysis (freya.DocChat), personalized alerts (freya.Alerts), dashboards (freya.Dashboards), and regulatory query drafting (freya.RTQ).

Key strengths for medical devices:

• Widest market coverage at 200+ markets, including markets in Africa, the Middle East, and Southeast Asia that are underserved by other platforms
• freya.KnowledgeGraphs that link internal knowledge with external regulations, enabling cross-country comparisons and enriched context
• Comprehensive product category coverage — valuable for companies producing drug-device combinations, IVDs with pharmaceutical components, or companies with diversified product portfolios
• Freya.RTQ (Regulatory Tracking and Queries) assists with drafting regulatory queries to health authorities, reducing the time to prepare formal correspondence
• Expert-verified insights layered on top of AI-generated analysis, providing an additional quality check

Limitations:

• The breadth of coverage comes with a trade-off in depth for any single category; device-specific intelligence may not be as deep as a device-only platform like Basil Systems
• Pricing is not published; contact vendor required
• The platform spans many product categories (cosmetics, food, chemicals), which may feel unfocused for a pure medical device company
• Newer AI features are still maturing; validate the accuracy of AI-generated regulatory assessments

Pricing: Contact vendor for pricing. No published rates.

Best for: Companies with diversified regulated product portfolios that need intelligence across medical devices, pharmaceuticals, cosmetics, and other categories. Also valuable for organizations targeting a large number of emerging markets where other platforms have thinner coverage.

---

8. Veeva Vault Regulatory — Best for End-to-End Regulatory Management

Veeva Vault Regulatory is the dominant regulatory information management platform in life sciences, used by 19 of the top 20 pharmaceutical companies and expanding its medical device capabilities. It is not primarily a regulatory intelligence tool — rather, it is a comprehensive RIM platform that includes regulatory submission management, registration tracking, health authority interactions, and document management. Regulatory intelligence capabilities exist within this broader context.

Key strengths for medical devices:

• End-to-end regulatory management: submission planning, content authoring, review and approval workflows, publishing, and archive — all in one platform
• Centralized document and workflow controls with strong audit trails, e-signatures, and 21 CFR Part 11 compliance
• Deep integration with Veeva's broader ecosystem (Vault Quality, Vault PromoMats, Vault Clinical) enables regulatory intelligence to flow into quality events, labeling changes, and promotional review
• Built-in AI features for content management and workflow automation
• MedTech-specific submission management capabilities, including support for eCTD 4.0 and global health authority interactions
• 450+ customers by 2025, providing a large user community and established best practices

Limitations:

• Regulatory intelligence is a feature within a larger RIM platform, not a standalone intelligence product — companies seeking dedicated regulatory monitoring should consider supplemental tools
• Pricing is enterprise-level and opaque; significant annual commitments required
• Implementation timelines are measured in months, not weeks; this is not a quick-deployment solution
• The platform's pharmaceutical heritage means some device-specific workflows require configuration rather than being available out-of-the-box
• Overkill for organizations that only need regulatory intelligence monitoring without full RIM capabilities

Pricing: Custom enterprise pricing. No published rates.

Best for: Large pharmaceutical and medical device organizations (500+ employees) that need regulatory intelligence as part of a comprehensive, enterprise-grade regulatory information management platform, particularly those already using other Veeva Vault applications.

How to Choose the Right Platform for Your Company

Step 1 — Define Your Buyer Profile

Your Profile	Recommended Platforms
Solo regulatory consultant	Obsidian (transparent pricing), Basil Systems (FDA intelligence)
Startup, 1–25 employees, 1–5 markets	RegDesk, Obsidian, Freyr RegIntel
Mid-size device company, 50–250 employees, multi-market	RegDesk, Basil Systems + Obsidian (combined)
Large enterprise, 500+ employees, global portfolio	IQVIA, Veeva Vault Regulatory, ArisGlobal LifeSphere
Consulting firm supporting device clients	Basil Systems, Obsidian
Drug-device combination manufacturer	Cortellis (Clarivate), Veeva Vault Regulatory
Diversified portfolio (devices + pharma + cosmetics)	Freyr RegIntel, IQVIA

Step 2 — Evaluate Pricing Transparency

Pricing opacity is a major issue in this market. Of the eight platforms reviewed, only Obsidian publishes its pricing model (per-user with volume discounts). The remaining seven require contacting sales for custom quotes. This creates several problems:

• It makes budget planning difficult, especially for startups and smaller companies
• It enables price discrimination based on company size and perceived ability to pay
• It extends the sales cycle, often requiring multiple calls and a formal procurement process before you see a number

If pricing transparency matters to your organization, Obsidian is the clear leader. For the rest, budget approximately $20,000–$100,000+ per year depending on company size and scope, and expect a 4–8 week sales process.

Step 3 — Distinguish Must-Have from Nice-to-Have Features

Must-have features for medical device companies:

• Real-time or daily regulatory change monitoring across your target markets
• Filtering by device classification, product code, and regulatory framework
• Source traceability for audit readiness (can you show an inspector where you learned about a change?)
• Impact assessment on your specific registrations and product portfolio
• Alert customization by market, product type, and regulatory topic

Nice-to-have features depending on your needs:

• AI-powered analysis and summarization of regulatory changes
• Competitive intelligence (competitor clearances, clinical trials, warning letters)
• Integration with your existing eQMS or RIM system
• Submission template generation and form pre-population
• Standards monitoring (ISO, IEC, ASTM) alongside regulatory tracking
• Multi-product category coverage (if you have diversified portfolios)

Step 4 — Assess Integration with Existing Systems

Regulatory intelligence does not exist in isolation. Consider how each platform connects to your current technology stack:

• If you use eQMS software like Greenlight Guru, MasterControl, or Qualio, check whether the intelligence platform can feed change notifications into your quality system's change control workflows
• If you have an existing RIM system (Veeva, ArisGlobal), evaluate whether adding that vendor's intelligence module is more efficient than integrating a third-party tool
• If you rely on consultants for regulatory strategy, tools like Basil Systems can supplement their expertise with data-driven predicate analysis and FDA trend intelligence — compare the cost against regulatory consulting hourly rates to assess value

Implementation Considerations

Timeline to Deploy

Regulatory intelligence platforms generally deploy faster than eQMS or full RIM systems, but timelines vary significantly:

Platform Type	Typical Deployment	Example Platforms
Standalone intelligence monitoring	1–4 weeks	Obsidian, Basil Systems
AI-powered intelligence + RIM	4–12 weeks	RegDesk, Freyr RegIntel
Enterprise RIM with intelligence module	3–12 months	Veeva Vault Regulatory, ArisGlobal LifeSphere, IQVIA

Data Migration

Unlike eQMS implementations, regulatory intelligence platforms typically do not require extensive data migration since the intelligence is drawn from the vendor's own databases. However, you will need to configure:

• Your product portfolio (device names, classifications, target markets, registration numbers)
• Alert preferences (which markets, which regulatory topics, which product categories)
• User accounts and permission structures
• Integration endpoints if connecting to your QMS or RIM system

Training Requirements

Most regulatory intelligence platforms are designed for self-service use by regulatory affairs professionals. Expect:

• 2–4 hours of platform orientation for basic users
• 1–2 days of training for administrators configuring alerts, filters, and integrations
• AI-powered features (chatbots, automated assessments) may require additional training to use effectively and to understand their limitations

Ongoing Maintenance

Factor in ongoing costs for:

• Annual subscription renewals (typically the largest cost component)
• User seat additions as your team grows
• Additional market or module access as you expand geographically
• Integration maintenance if connected to your QMS or RIM system
• Periodic review of alert configurations to reduce noise and improve relevance

Recommended Reading

Coordinated Vulnerability Disclosure for Medical Devices: Building a Post-Market Cybersecurity Program

Cybersecurity Regulatory2026-04-30 · 11 min read

Common Mistakes When Choosing Regulatory Intelligence Software

1. Choosing a Pharma-First Platform for a Device-Only Company

Several platforms on this list (IQVIA, Cortellis, ArisGlobal) were built primarily for pharmaceutical companies and added medical device coverage later. If you are a pure medical device company, you may find that device-specific features feel like afterthoughts and that the pricing reflects the broader pharma value proposition. Evaluate whether the device coverage depth justifies the pharma-grade pricing.

2. Overlooking Source Traceability

During regulatory audits, inspectors may ask how your organization stays informed about regulatory changes. If your intelligence platform provides analyst summaries without links to official source documents, you may struggle to demonstrate proactive monitoring. Platforms like Obsidian that link every alert to the original government source provide stronger audit support.

3. Ignoring Alert Fatigue

The most common complaint about regulatory intelligence platforms is alert overload — receiving hundreds of notifications per week, most of which are irrelevant to your products. During evaluation, test the filtering capabilities specifically. Can you filter by your exact device classifications, product codes, and target markets? Generic "medical device" alerts are not sufficient.

4. Paying for Coverage You Don't Need

A platform covering 200 markets sounds impressive, but if you only sell in 5–10 countries, you are subsidizing coverage you don't use. Conversely, if you plan to expand into emerging markets, you want a platform that already covers those markets rather than one you will outgrow.

5. Not Validating AI-Generated Assessments

Most platforms now incorporate AI for summarization, impact assessment, and query drafting. These features can save significant time, but AI-generated regulatory analysis is not infallible. Establish a process where AI outputs are reviewed by qualified regulatory professionals before they inform strategic decisions. This is particularly important for medical devices where classification nuances and jurisdiction-specific requirements can be subtle.

Key Takeaways

• RegDesk offers the tightest integration between regulatory intelligence and submission management for multi-market medical device teams, but pricing is opaque
• IQVIA provides the broadest ecosystem for organizations already invested in its platform, though device-specific depth is limited
• Cortellis (Clarivate) has the deepest pharmaceutical regulatory database with strong AI capabilities, but medical device coverage is secondary
• Obsidian is the only platform with published pricing and audit-traceable official-source monitoring — a refreshing exception in an opaque market
• Basil Systems provides unmatched FDA device intelligence for 510(k) and PMA strategy but is not a broad regulatory monitoring tool
• ArisGlobal LifeSphere delivers the most advanced AI capabilities (NavaX GenAI/Agentic AI) within an integrated RIM ecosystem
• Freyr RegIntel offers the widest market coverage (200+ markets) and multi-product-category support, valuable for diversified companies
• Veeva Vault Regulatory is the enterprise standard for end-to-end RIM but is overkill if you only need regulatory intelligence monitoring
• No single platform is best for everyone — the right choice depends on your company size, target markets, product portfolio, existing technology stack, and whether you need standalone intelligence or integrated RIM

Frequently Asked Questions

What is regulatory intelligence software?

Regulatory intelligence software monitors regulatory agencies, health authorities, and standards bodies worldwide for changes that affect medical device and IVD manufacturers. It delivers filtered alerts, analysis, and actionable intelligence to regulatory affairs teams so they can maintain compliance, plan submissions, and respond to regulatory changes proactively rather than reactively.

How much does regulatory intelligence software cost?

Pricing varies enormously. The only platform with published pricing is Obsidian, which offers per-user subscriptions with volume discounts. For the remaining platforms, annual costs typically range from $20,000 for basic monitoring tools to $100,000+ for enterprise-grade RIM-integrated intelligence. Contact each vendor for specific quotes, and budget for 20–30% additional costs for implementation, training, and integration.

Can regulatory intelligence software replace my regulatory affairs team?

No. These tools augment regulatory professionals by reducing manual monitoring time and surfacing relevant changes, but they do not replace human judgment for regulatory strategy, submission preparation, or health authority interactions. AI-powered features can assist with drafting and analysis, but all outputs should be reviewed by qualified professionals. Think of these platforms as giving your team better information faster — not as replacing them.

What is the difference between regulatory intelligence and regulatory information management (RIM)?

Regulatory intelligence focuses on monitoring and analyzing external regulatory changes — new guidance documents, classification changes, deadline extensions, standards updates. RIM focuses on managing your organization's internal regulatory data — registrations, submissions, health authority correspondence, product portfolios. Some platforms (RegDesk, Veeva, ArisGlobal) combine both capabilities. Others (Obsidian, Basil Systems) focus primarily on intelligence.

How do I evaluate which platform is right for my company?

Start by listing your target markets, product types (devices, IVDs, drug-device combinations), team size, and existing technology stack. Then request demos from 2–3 platforms that match your profile, specifically testing: (1) alert relevance for your exact product classifications, (2) source traceability for audit readiness, (3) integration with your current QMS or RIM, and (4) total cost including implementation and training. Do not skip the demo — marketing materials do not reveal the user experience.

Should I use multiple regulatory intelligence tools?

Some companies combine platforms — for example, using Basil Systems for deep FDA device intelligence alongside Obsidian for broad regulatory monitoring. This approach can be effective if no single platform meets all your needs, but it increases cost, creates duplicate alerts, and requires managing multiple vendor relationships. Start with one platform that covers 80% of your needs, then evaluate whether gaps justify adding a second tool.